US$ 23.36
glp-1 receptor agonist brands list glp 1 agonists brand names Understanding Agonists: Key Insights for Payers GLP-1 Costs Explained: Managing Coverage
Description
Comprehensive long-term studies will help clarify the risk-benefit ratio of prolonged GLP-1 RA therapy

By comparison, the STEP 1 trial for semaglutide reported 14.9% at 68 weeks, and SURMOUNT-1 for tirzepatide reported 20.9% at 72 weeks

Quality of Care: Check out customer reviews and satisfaction scores

The brand names are Mounjaro (approved for type 2 diabetes) and Zepbound (approved specifically for weight management)
